Tüdőrák trials, also abroad
2747 open Tüdőrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Kína | 1143 |
| Egyesült Államok | 901 |
| Franciaország | 315 |
| Spanyolország | 273 |
| Olaszország | 272 |
| All other countries |
The same trial often runs in several countries
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) has 2 sites in Szlovákia and runs in 36 countries. If a site near you is full, another one may still take people.
See A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) in all 36 countries